Lihua Wen

Lihua Pharmaceutical is a China-based pharmaceutical company specializing in the development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in corticosteroid and hormone-based therapies, maintaining significant production capacity for products like hydrocortisone and prednisolone. Lihua operates high-standard manufacturing facilities that comply with international GMP standards, including certifications from the FDA and EDQM. In addition to its own product portfolio, the company serves as a contract manufacturing partner for global pharmaceutical firms, leveraging its large-scale chemical synthesis capabilities.